News
Funding will be specifically used to accelerate the clinical development of urcosimod (formerly called OK-101).
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback